Rallybio Corp (RLYB) stock
RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.26−0.03 (-0.20%)
Close on Nov 18, 2026Market cap $82.16MP/E 3.3Yield –
Rallybio pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Rallybio's pe ratio was 2.0× on Nov 11, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.0× | – |
See a number that looks wrong?